Comments on Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation [Response To Letter].

Tobaiqy M, Alqutub ST

Open source

DOI
10.2147/dddt.s655784
Published
2026
Container
Drug design, development and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/dddt.s655784,
  title = {Comments on Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation [Response To Letter].},
  author = {Tobaiqy M and Alqutub ST},
  year = {2026},
  journal = {Drug design, development and therapy},
  doi = {10.2147/dddt.s655784},
  url = {https://doi.org/10.2147/dddt.s655784}
}

RIS

TY  - JOUR
TI  - Comments on Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation [Response To Letter].
AU  - Tobaiqy M
AU  - Alqutub ST
PY  - 2026
JO  - Drug design, development and therapy
DO  - 10.2147/dddt.s655784
UR  - https://doi.org/10.2147/dddt.s655784
ER  - 

APA

M, T., & ST, A. (2026). Comments on Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation [Response To Letter].. Drug design, development and therapy. https://doi.org/10.2147/dddt.s655784

Source records